Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: Cognitive impairment and clozapine treatment

Psychiatry Research

Volumn 178, Issue 1, 2010, Pages 57-62

  Kaneda, Yasuhiro ^a   Jayathilak, Karuna ^b   Meltzer, Herbert ^b  

^a Iwaki Clinic   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult; Open studies; Pharmacotherapy; Verbal working memory

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; EMPLOYMENT STATUS; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; VERBAL MEMORY; WORK CAPACITY; WORKING MEMORY;

EID: 80054902843     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.04.001     Document Type: Article

References (64)

1. Aitchison, K.J., Kerwin, R.W., 1997. Cost-effectiveness of clozapine: a UK clinic-based study. British Journal of Psychiatry 171, 125-130.
2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. American Psychiatric Association, Washington, D.C. Revised (DSM-III-R).
3. Anonymous [http://www.schizophrenia.com/news/costs1.html].
4. Beiser, M., Bean, G., Erickson, D., Zhang, J., Iacono,W.G., Rector, N.A., 1994. Biological and psychosocial predictors of job performance following a first episode of psychosis. American Journal of Psychiatry 151 (6), 857-863.
5. Bell, M.D., Bryson, G., 2001. Work rehabilitation in schizophrenia: does cognitive impairment limit improvement? Schizophrenia Bulletin 27 (2), 269-279.
6. Benton, A.L., Hamsher, K., Verney, N.R., Spreen, D., 1983. Contributions to Neuropsychological Assessment. Oxford University Press, New York.
7. Berg, E., 1948. A simple objective test for measuring flexibility in thinking. Journal of General Psychology 39, 15-22.
8. Breier, A., Schreiber, J.L., Dyer, J., Pickar, D., 1991. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry 48 (3), 239-246.
9. Bryson, G., Bell,M.D., 2003. Initial and final work performance in schizophrenia: cognitive and symptom predictors. Journal of Nervous and Mental Disease 191 (2), 87-92.
10. Bryson, G., Bell, M.D., Kaplan, E., Greig, T., 1998. The functional consequences of memory impairments on initial work performance in people with schizophrenia. Journal of Nervous and Mental Disease 186 (10), 610-615.
11. Buchanan, R.W., Breier, A., Kirkpatrick, B., Ball, P., Carpenter Jr., W.T., 1998. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. American Journal of Psychiatry 155 (6), 751-760.
12. Buschke, H., Fuld, P.A., 1974. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24 (11), 1019-1025.
13. Daradkeh, T.K., Karim, L., 1994. Predictors of employment status of treated patients with DSM-III-R diagnosis. Can logistic regression model find a solution? International Journal of Social Psychiatry 40 (2), 141-149.
14. Drew, L.R., Hodgson, D.M., Griffiths, K.M., 1999. Clozapine in community practice: a 3-year follow-up study in the Australian Capital Territory. Australian and New Zealand Journal of Psychiatry 33 (5), 667-675.
15. Endicott, J., Spitzer, R.L., 1978. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35 (7), 837-844.
16. Ertugrul, A., Ulug, B., 2002. The influence of neurocognitive deficits and symptoms on disability in schizophrenia. Acta Psychiatrica Scandinavica 105 (3), 196-201.
17. Gold, J.M., Goldberg, R.W., McNary, S.W., Dixon, L.B., Lehman, A.F., 2002. Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry 159 (8), 1395-1402.
18. Goldberg, R.W., Lucksted, A., McNary, S., Gold, J.M., Dixon, L., Lehman, A., 2001. Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness. Psychiatric Services 52 (1), 101-103.
19. Green, M.F., 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153 (3), 321-330.
20. Green, M.F., Kern, R.S., Braff, D.L., Mintz, J., 2000. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bulletin 26 (1), 119-136.
21. Hagger, C., Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., Meltzer, H.Y., 1993. Improvement in cognitive functions and psychiatric symptoms in treatmentrefractory schizophrenic patients receiving clozapine. Biological Psychiatry 34 (10), 702-712.
22. Harvey, P.D., Keefe, R.S., 2001. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. American Journal of Psychiatry 158 (2), 176-184.
23. Hoffmann, H., Kupper, Z., Zbinden, M., Hirsbrunner, H.P., 2003. Predicting vocational functioning and outcome in schizophrenia outpatients attending a vocational rehabilitation program. Social Psychiatry and Psychiatric Epidemiology 38 (2), 76-82.
24. Jaeger, J., Douglas, E., 1992. Neuropsychiatric rehabilitation for persistent mental illness. Psychiatric Quarterly 63 (1), 71-94.
25. Kane, J., Honigfeld, G., Singer, J., Meltzer, H., 1988. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 45 (9), 789-796.
26. Keefe, R.S., Bilder, R.M., Davis, S.M., Harvey, P.D., Palmer, B.W., Gold, J.M., Meltzer, H.Y., Green, M.F., Capuano, G., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Davis, C.E., Hsiao, J.K., Lieberman, J.A., 2007. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64 (6), 633-647.
27. Keefe, R.S., Silva, S.G., Perkins, D.O., Lieberman, J.A., 1999. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophrenia Bulletin 25 (2), 201-222.
28. Kenny, J.T., Meltzer, H.Y., 1991. Attention and higher cortical functions in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences 3 (3), 269-275.
29. Lee, M.A., Jayathilake, K., Meltzer, H.Y., 1999. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia Research 37 (1), 1-11.
30. Lee, M.A., Thompson, P.A., Meltzer, H.Y., 1994. Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry 55 (Suppl B), 82-87.
31. Lehman, A.F., Goldberg, R., Dixon, L.B.,McNary, S., Postrado, L., Hackman, A., McDonnell, K., 2002. Improving employment outcomes for persons with severe mental illnesses. Archives of General Psychiatry 59 (2), 165-172.
32. Lindström, L.H., 1988. The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatrica Scandinavica 77 (5), 524-529.
33. Lindström, L.H., Lundberga, T., 1997. Long-term effect on outcome of clozapine in chronic therapy-resistant schizophrenic patients. European Psychiatry 12 (Suppl 5), 353s-355s.
34. Lysaker, P., Bell, M., Beam-Goulet, J., 1995. Wisconsin card sorting test and work performance in schizophrenia. Psychiatry Research 56 (1), 45-51.
35. Martinez-Aran, A., Penades, R., Vieta, E., Colom, F., Reinares, M., Benabarre, A., Salamero, M., Gasto, C., 2002. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychotherapy and Psychosomatics 71 (1), 39-46.
36. McGurk, S.R., Meltzer, H.Y., 2000. The role of cognition in vocational functioning in schizophrenia. Schizophrenia Research 45 (3), 175-184.
37. McGurk, S.R., Mueser, K.T., 2003. Cognitive functioning and employment in severe mental illness. Journal of Nervous and Mental Disease 191 (12), 789-798.
38. McGurk, S.R., Mueser, K.T., Harvey, P.D., LaPuglia, R., Marder, J., 2003. Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatric Services 54 (8), 1129-1135.
39. McHugo, G.J., Drake, R.E., Becker, D.R., 1998. The durability of supported employment effects. Psychiatric Rehabilitation Journal 22 (1), 55-61.
40. Meltzer, H.Y., 1997. Treatment-resistant schizophrenia-the role of clozapine. Current Medical Research and Opinion 14 (1), 1-20.
41. Meltzer, H.Y., Burnett, S., Bastani, B., Ramirez, L.F., 1990. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hospital and Community Psychiatry 41 (8), 892-897.
42. Meltzer, H.Y., Cola, P., Way, L., Thompson, P.A., Bastani, B., Davies, M.A., Snitz, B., 1993. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry 150 (11), 1630-1638.
43. Meltzer, H.Y., McGurk, S.R., 1999. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25 (2), 233-255.
44. Meltzer, H.Y., Thompson, P.A., Lee, M.A., Ranjan, R., 1996. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 14 (3 Suppl), 27s-33s.
45. Meyer, P.S., Bond, G.R., Tunis, S.L., McCoy, M.L., 2002. Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program. Journal of Clinical Psychiatry 63 (2), 108-116.
46. Milev, P., Ho, B.C., Arndt, S., Andreasen, N.C., 2005. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162 (3), 495-506.
47. Mohamed, S., Paulsen, J.S., O'Leary, D., Arndt, S., Andreasen, N., 1999. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Archives of General Psychiatry 56 (8), 749-754.
48. Mohamed, S., Rosenheck, R., Swartz, M., Stroup, S., Lieberman, J.A., Keefe, R.S., 2008. Relationship of cognition and psychopathology to functional impairment in schizophrenia. American Journal of Psychiatry 165 (8), 978-987.
49. Mueser, K.T., 2002. Cognitive impairment, symptoms, social functioning, and vocational rehabilitation in schizophrenia. Springer, Tokyo.
50. Mueser, K.T., Salyers, M.P., Mueser, P.R., 2001. A prospective analysis of work in schizophrenia. Schizophrenia Bulletin 27 (2), 281-296.
51. Mulkern, V.M., Manderscheid, R.W., 1989. Characteristics of community support program clients in 1980 and 1984. Hospital and Community Psychiatry 40 (2), 165-172.
52. Norman, R.M., Malla, A.K., Cortese, L., Cheng, S., Diaz, K., McIntosh, E., McLean, T.S., Rickwood, A., Voruganti, L.P., 1999. Symptoms and cognition as predictors of community functioning: a prospective analysis. American Journal of Psychiatry 156 (3), 400-405.
53. Overall, J.E., Gorham, D.R., 1962. The brief psychiatric rating scale. Psychological Reports 10, 799-812.
54. Palmer, B.W., Heaton, R.K., Gladsjo, J.A., Evans, J.D., Patterson, T.L., Golshan, S., Jeste, D.V., 2002. Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophrenia Research 55 (3), 205-215.
55. Percudani, M., Barbui, C., Tansella, M., 2004. Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective. Pharmacoeconomics 22 (11), 701-718.
56. Peterson, L., Peterson, M.J., 1959. Short-term retention of individual verbal items. Journal of Experimental Psychology 58, 193-198.
57. Saykin, A.J., Shtasel, D.L., Gur, R.E., Kester, D.B., Mozley, L.H., Stafiniak, P., Gur, R.C., 1994. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry 51 (2), 124-131.
58. Slade, E., Salkever, D., 2001. Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia. Journal of Mental Health Policy and Economics 4 (1), 25-34.
59. Smith, T.E., Hull, J.W., Huppert, J.D., Silverstein, S.M., 2002. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive ratelimiters for the development of social behavior skills. Schizophrenia Research 55 (3), 229-237.
60. Suslow, T., Schonauer, K., Ohrmann, P., Eikelmann, B., Reker, T., 2000. Prediction of work performance by clinical symptoms and cognitive skills in schizophrenic outpatients. Journal of Nervous and Mental Disease 188 (2), 116-118.
61. Talland, G.A., 1965. Deranged Memory. Academic Press, New York.
62. Wechsler, D., 1974. WISC-R Manual. The Psychological Corporation, New York.
63. Wechsler, D., 1981. Manual for the Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, New York.
64. Woodward, N.D., Purdon, S.E., Meltzer, H.Y., Zald, D.H., 2005. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology 8 (3), 457-472.